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Dear Editor,
The term ‘‘medical devices’’ covers a wide range of health
or medical instruments used directly or indirectly in
medicine, dentistry, physical therapy, and laboratory
practice for the diagnosis, rehabilitation, therapy, and
monitoring of human beings, as well as for aesthetic
purposes.
The National Health Surveillance Agency (Ageˆncia
Nacional de Vigilaˆncia Sanita´ria – ANVISA)1 is responsible
for the registration of medical devices in Brazil and assigns a
unique 11-digit identification number to each device,
according to specific resolutions.
According to ANVISA,1 all medical devices are regulated
by the Brazilian Ministry of Health, under Article 12 of Law
No. 6360 of September 23, 1976, published in the Official
Gazette of September 24, 1976. This Article regulates the
manufacture, use, and sale of medical devices in Brazil.
All medical devices have to be registered and/or listed
with ANVISA.
Listing is the first step in the registration process of all
medical devices. This is a simple process that applies to
medical devices classified according to the first paragraph
of Article 25 of Law No. 6360 as Class I and Class II, which
do not require registration under Resolution RDC ANVISA
24 of May, 1999.
On the other hand, some medical devices require
registration, even if classified as Class I or Class II, because
of the potential risk involved, as indicated in Resolution
RDC ANVISA 185 of October 22, 1999, and other comple-
mentary regulations also used in this process.
The requirement for medical device registration and/or
listing with ANVISA is determined by the classification of
the device into four risk classes (I to IV) based on 18
classification rules. Classes I, II, III and IV represent low-,
medium-, high- and very-high-risk devices, respectively.
Thus, medical devices classified as Class I and Class II
may or may not require registration depending on their use,
because they pose a low risk to the patient. Class III and
Class IV devices require listing and registration, and all the
parameters and specifications of the device have to be given
during the registration process.
The classification rules for the registration of medical
devices are based on the evaluation of risks arising from the
application and use of the devices.
Medical devices used in physical therapy are considered
active devices, meaning that a power supply is required for
their operation. These devices can be classified based on
four rules, of which the most important one (Rule 9) refers
to ‘‘active therapeutic devices intended to deliver energy to
or exchange energy with the human body’’, including
electrophysical agents used in the clinical practice to
facilitate wound healing, analgesia, edema reduction, and
modulation of the inflammatory process.
Most of the electrophysical instruments used in physical
therapy for tissue repair are classified as Class II devices
and only require to be listed. Examples of Class II devices
include equipment used in ultraviolet phototherapy, ultra-
sound therapy, pulsed electromagnetic field therapy,
electric stimulation therapy, laser therapy, and light-emit-
ting diode therapy.
Regardless of their therapeutic use and classification, all
medical devices should necessarily be registered with the
provision of clear specifications, and their safety for use in
the clinical practice should be determined on the basis of
clinical trials.
Therefore, even devices for aesthetic treatments or those
used by technicians, such as estheticians, should have
reliable operating parameters, allowing them to be tested in
scientific studies.
The search for agents that can influence the wound-
healing process by accelerating the different phases of
wound healing and reducing healing time, and that can
improve functional and aesthetic results, is still a challenge
in the field of surgery.
Experimental studies have indicated that the use of
medical devices have a beneficial effect on the healing of
skin wounds, contributing to the modulation of the
inflammatory process,2,3 stimulation of angiogenesis,2,4
proliferation of fibroblasts2,3,5 and myofibroblasts,6–8
deposition of collagen,3 and proliferation of keratinocytes.9
From these studies, it was possible to advance to clinical
trials and adjust the specifications of these devices for use in
clinical practice.
As an example, there is an electrophysical device
available in the market, called the ‘‘high-frequency
machine’’, which has been used for many years for facial
and body aesthetic treatments. The literature and manufac-
turers suggest that this device produces therapeutic effects
similar to those obtained from the topical application of
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ozone, and is indicated for the healing of skin wounds,
surgical wound dehiscence, and treatment of fungal
lesions.10–15 However, scientifically rigorous studies are
necessary to determine the veracity of these claims, because
the reported performance of this device is based on
unreliable studies, and to date no study on this device has
been published in the peer-reviewed medical literature.
According to ANVISA, the high-frequency machine is
classified as a Class I device, meaning that it is a device for
aesthetic treatments and is considered to pose a low risk to
the patient. Therefore, the manufacturer is not required to
register this device and disclose all technical specifications
in order to standardize its applications, even though there
may be risks and contraindications associated with its use.
Thus, like other medical devices for therapeutic use, the
registration and control of the specifications and parameters
of such a device would be of considerable importance.
Moreover, the registration of all medical devices should be
mandatory.
All these biophysical agents have specific indications and
contraindications, have the potential to produce skin
lesions, such as burns, and may negatively impact the
health of patients with pacemakers, malignant tumors or
thrombophlebitis, among other things.
On the basis of the classification system (classes I to IV) for
medical devices, ANVISA does not require scientific studies
to be performed to determine the actual effects and risks of
Class I and Class II devices. This trivializes their use and
allows non-medically qualified practitioners to operate them.
Therefore, the goal of this Letter to the Editor is to alert the
community to the current system of risk categorization of
medical devices used by ANVISA, which can result in losses
and harm to the patient caused by the use of a device.
In conclusion, we believe that it is important to call the
attention of health officials to the need for standardization
of the parameters and specifications of medical devices, so
that their therapeutic use can follow guidelines developed
on the basis of scientifically rigorous studies, providing
increased safety to patients treated with such devices.
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